Mikhail Doubrovin, MD

Nuclear Medicine
Accepting New Patients
Profile Headshot


With background both in clinical and basic science Molecular Imaging and Therapy, Dr. Doubrovin is experienced in all aspects of Nuclear Medicine applications. Most of his clinical and research interest is focused on use of radiopharmaceuticals in diagnosis and treatment of cancer. He is also involved in development of and monitoring of immune cell therapy for cancer and allied diseases. During his previous practice at MSKCC and St. Jude Children's Research Hospital, Dr. Doubrovin paid special attention to treatment of children and young adults. Dr. Doubrovin is member of the Society of Nuclear Medicine and Molecular Imaging and the World Molecular Imaging Society.

Areas of Expertise / Conditions Treated

  • Nuclear Cardiac Imaging
  • Nuclear Cardiology
  • Nuclear Imaging
  • Nuclear Medicine and PET/CT
  • PET (Positron Emission Tomography)
  • PET Scan
  • Radionuclide therapy for thyroid cancer and prostate cancer

Academic Appointments

  • Associate Professor of Radiology at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Allen Hospital


  • Russian


  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Education & Training

  • Russian State Medical University
  • Residency: Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Committees, Societies, Councils

  • Society of Nuclear Medicine and Molecular Imaging
  • World Molecular Imaging Society

Board Certifications

  • Nuclear Medicine


Selected Publications

  • Hsu CY, Doubrovin M, et al., Radiomics Features Differentiate Between Normal and Tumoral High-Fdg Uptake. Sci Rep. 2018 PubMed PMID: 29500442;
  • Harreld JH, Doubrovin M, Butch ER, Edwards A, Shulkin B. Developmental Venous Anomalies Mimicking Neoplasm on 11C-Methionine PET and DSC Perfusion MRI. Clin Nucl Med. 2017 PubMed PMID: 28319499;
  • Doubrovin M, Che JT, et al., Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino-demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging. Mol Imaging. 2012 . PubMed PMID: 22418029;
  • Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CG, Scallion MI, Doubrovin M, Heller G, Younes A, O'Reilly RJ, van den Brink MR, Zakrzewski JL. Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses. Cancer Res. 2016 PubMed PMID: 26744524;
  • Barker JN, Doubrovina E, Sauter C, Jaroscak JJ, Perales MA, Doubrovin M, Prockop SE, Koehne G, O'Reilly RJ. Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 2010 PubMed PMID: 20826724;
  • Doubrovin M, Kochetkova T, Santos E, Veach DR, Smith-Jones P, Pillarsetty N, Balatoni J, Bornmann W, Gelovani J, Larson SM. (124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo. J Nucl Med. 2010 PubMed PMID: 20048131;

  • Doubrovin MM, Doubrovina ES, Zanzonico P, Sadelain M, Larson SM, O'Reilly RJ. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res. 2007. PubMed PMID: 18089827.